nystatin-a1 and betamethasone-17-21-dipropionate

nystatin-a1 has been researched along with betamethasone-17-21-dipropionate* in 1 studies

Other Studies

1 other study(ies) available for nystatin-a1 and betamethasone-17-21-dipropionate

Article	Year
Severe vulvovaginitis associated with intravaginal nystatin therapy. American journal of obstetrics and gynecology, 2001, Volume: 185, Issue:1 A 64-year-old woman had severe vulvovaginitis develop while she was receiving intravaginal nystatin therapy for Candida glabrata infection. Mucocutaneous adverse effects have rarely been reported with nystatin despite long years of use. This complication should be included in the differential diagnosis of clinical failure of intravaginal nystatin therapy. Topics: Administration, Intravaginal; Anti-Inflammatory Agents; Antifungal Agents; Betamethasone; Candidiasis; Edema; Erythema; Female; Humans; Hydrocortisone; Middle Aged; Nystatin; Vulvovaginitis	2001

Article

Year

Severe vulvovaginitis associated with intravaginal nystatin therapy.

American journal of obstetrics and gynecology, 2001, Volume: 185, Issue:1

A 64-year-old woman had severe vulvovaginitis develop while she was receiving intravaginal nystatin therapy for Candida glabrata infection. Mucocutaneous adverse effects have rarely been reported with nystatin despite long years of use. This complication should be included in the differential diagnosis of clinical failure of intravaginal nystatin therapy.

Topics: Administration, Intravaginal; Anti-Inflammatory Agents; Antifungal Agents; Betamethasone; Candidiasis; Edema; Erythema; Female; Humans; Hydrocortisone; Middle Aged; Nystatin; Vulvovaginitis

2001